Allogene Therapeutics (ALLO) Short-term Investments (2018 - 2026)
Allogene Therapeutics (ALLO) recorded Short-term Investments of $293.98 million in Q2 2026, up 33.1% from $220.79 million a year earlier and up 24.3% from the prior quarter.
Allogene Therapeutics (ALLO) Short-term Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Allogene Therapeutics reported Short-term Investments of $198.52 million, down 8.6% from FY2024.
- Annual Short-term Investments has declined for three straight years, with a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
- Across earlier years, Short-term Investments came in at $217.26 million in FY2024 (-40.6%), $365.54 million in FY2023 (-19.7%), $455.42 million in FY2022 (+60.4%) and $283.99 million in FY2021 (-55.9%).
- The Q2 2026 figure is the highest quarterly Short-term Investments since Q1 2024.
- On a year-over-year basis, Short-term Investments rose in 1 of the last eight quarters, with an average decline of 14.4%.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 62.8% in Q3 2022, against a decline of 57.0% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $236.58 million (Q1 2026), $198.52 million (Q4 2025) and $214.38 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Allogene Therapeutics | 322.04 Mn | -820.62 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 263.69 Mn |
| Jun 30, 2026 | 293.98 Mn |
| Mar 31, 2026 | 236.58 Mn |
| Dec 31, 2025 | 198.52 Mn |
| Sep 30, 2025 | 214.38 Mn |
| Jun 30, 2025 | 220.79 Mn |
| Mar 31, 2025 | 237.59 Mn |
| Dec 31, 2024 | 217.26 Mn |
| Sep 30, 2024 | 240.33 Mn |
| Jun 30, 2024 | 273.96 Mn |
| Mar 31, 2024 | 333.82 Mn |
| Dec 31, 2023 | 365.54 Mn |
| Sep 30, 2023 | 396.26 Mn |
| Jun 30, 2023 | 337.20 Mn |
| Mar 31, 2023 | 361.29 Mn |
| Dec 31, 2022 | 455.42 Mn |
| Sep 30, 2022 | 477.87 Mn |
| Jun 30, 2022 | 394.45 Mn |
| Mar 31, 2022 | 364.54 Mn |
| Dec 31, 2021 | 283.99 Mn |
Allogene Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ALLO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();